These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35116583)

  • 41. RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence.
    Nakano M; Fukami T; Gotoh S; Takamiya M; Aoki Y; Nakajima M
    J Biol Chem; 2016 Jan; 291(2):894-903. PubMed ID: 26601943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.
    Nakano M; Fukami T; Gotoh S; Nakajima M
    J Biol Chem; 2017 Mar; 292(12):4873-4884. PubMed ID: 28188287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel Engineered Programmable Systems for ADAR-Mediated RNA Editing.
    Aquino-Jarquin G
    Mol Ther Nucleic Acids; 2020 Mar; 19():1065-1072. PubMed ID: 32044725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adenosine-to-inosine RNA editing.
    Zinshteyn B; Nishikura K
    Wiley Interdiscip Rev Syst Biol Med; 2009; 1(2):202-209. PubMed ID: 20835992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biochemical and Transcriptome-Wide Identification of A-to-I RNA Editing Sites by ICE-Seq.
    Okada S; Sakurai M; Ueda H; Suzuki T
    Methods Enzymol; 2015; 560():331-53. PubMed ID: 26253977
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.
    Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA
    RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A high-throughput screen to identify enhancers of ADAR-mediated RNA-editing.
    Garncarz W; Tariq A; Handl C; Pusch O; Jantsch MF
    RNA Biol; 2013 Feb; 10(2):192-204. PubMed ID: 23353575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ADAR enzyme and miRNA story: a nucleotide that can make the difference.
    Tomaselli S; Bonamassa B; Alisi A; Nobili V; Locatelli F; Gallo A
    Int J Mol Sci; 2013 Nov; 14(11):22796-816. PubMed ID: 24256817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fmrp Interacts with Adar and Regulates RNA Editing, Synaptic Density and Locomotor Activity in Zebrafish.
    Shamay-Ramot A; Khermesh K; Porath HT; Barak M; Pinto Y; Wachtel C; Zilberberg A; Lerer-Goldshtein T; Efroni S; Levanon EY; Appelbaum L
    PLoS Genet; 2015 Dec; 11(12):e1005702. PubMed ID: 26637167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A-to-I RNA editing promotes developmental stage-specific gene and lncRNA expression.
    Goldstein B; Agranat-Tamir L; Light D; Ben-Naim Zgayer O; Fishman A; Lamm AT
    Genome Res; 2017 Mar; 27(3):462-470. PubMed ID: 28031250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Significance of A-to-I RNA editing of transcripts modulating pharmacokinetics and pharmacodynamics.
    Nakano M; Nakajima M
    Pharmacol Ther; 2018 Jan; 181():13-21. PubMed ID: 28716651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms and implications of ADAR-mediated RNA editing in cancer.
    Wang C; Zou J; Ma X; Wang E; Peng G
    Cancer Lett; 2017 Dec; 411():27-34. PubMed ID: 28974449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of constitutive A-to-I editing sites from human transcriptomes in the absence of genomic sequences.
    Zhu S; Xiang JF; Chen T; Chen LL; Yang L
    BMC Genomics; 2013 Mar; 14():206. PubMed ID: 23537002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcriptome-wide identification of A > I RNA editing sites by inosine specific cleavage.
    Cattenoz PB; Taft RJ; Westhof E; Mattick JS
    RNA; 2013 Feb; 19(2):257-70. PubMed ID: 23264566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ADAR1 and MicroRNA; A Hidden Crosstalk in Cancer.
    Cho CJ; Myung SJ; Chang S
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Artificial RNA Editing with ADAR for Gene Therapy.
    Bhakta S; Tsukahara T
    Curr Gene Ther; 2020; 20(1):44-54. PubMed ID: 32416688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bidirectional regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box helicase 9 (DHX9) in cancer.
    Hong H; An O; Chan THM; Ng VHE; Kwok HS; Lin JS; Qi L; Han J; Tay DJT; Tang SJ; Yang H; Song Y; Bellido Molias F; Tenen DG; Chen L
    Nucleic Acids Res; 2018 Sep; 46(15):7953-7969. PubMed ID: 29796672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Zinc Finger RNA-Binding Protein Zn72D Regulates ADAR-Mediated RNA Editing in Neurons.
    Sapiro AL; Freund EC; Restrepo L; Qiao HH; Bhate A; Li Q; Ni JQ; Mosca TJ; Li JB
    Cell Rep; 2020 May; 31(7):107654. PubMed ID: 32433963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The adaptive potential of RNA editing-mediated miRNA-retargeting in cancer.
    Tassinari V; Cesarini V; Silvestris DA; Gallo A
    Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):291-300. PubMed ID: 30605729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disruption in A-to-I Editing Levels Affects C. elegans Development More Than a Complete Lack of Editing.
    Ganem NS; Ben-Asher N; Manning AC; Deffit SN; Washburn MC; Wheeler EC; Yeo GW; Zgayer OB; Mantsur E; Hundley HA; Lamm AT
    Cell Rep; 2019 Apr; 27(4):1244-1253.e4. PubMed ID: 31018137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.